A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer.

150 mg orally daily Days 15 to 28 of each 4-week cycle for 6 cycles, followed by 150 mg orally daily

orally daily Days 15 to 28 of each 4-week cycle for 6 cycles, followed by daily oral application

1250 mg/m2 iv Days 1 and 8 of each 4-week cycle, 6 cycles

75 mg/m2 iv Day 1 of each 4.wek cycle, 6 cycles; or carboplatin

5 x AUC iv Day 1 of each 4.week cycle, 6 cycles; or cisplatin